---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-038506"
form_type: "8-K"
ticker: "CGON"
cik: "0001991792"
company_name: "CG Oncology, Inc."
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:28:08.731100+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# CG Oncology discloses 2023 executive bonuses in amended summary comp table

## Summary
- CEO Arthur Kuan awarded $189,000 performance bonus for 2023; total comp $3.93M.
- COO Ambaw Bellete received $189,500 sign-on bonus plus $179,740 performance bonus; total $3.03M.
- CMO Vijay Kasturi received $56,000 sign-on bonus plus $87,448 performance bonus; total $2.44M.
- Bonuses omitted from Jan 2024 IPO prospectus; now reported in Item 5.02 filing.

## SEC filing metadata
- accession: 0001193125-24-038506
- form_type: 8-K
- ticker: CGON
- cik: 0001991792
- company_name: CG Oncology, Inc.
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1991792/000119312524038506/0001193125-24-038506-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1991792/000119312524038506/d773011d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-038506
- JSON: https://secwatch.observer/filing/0001193125-24-038506.json
- Plain text: https://secwatch.observer/filing/0001193125-24-038506.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.